DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here
Understand the complete disease landscape and size global markets with real world data

  • Benchmark your forecasts with data on the total potential and addressable market
  • Validate your investments using bottom-up forecasting
  • Identify growth opportunities and understand how populations will change over time
  • Confidently estimate drug-treated populations with additional insights from therapeutic experts and primary market research

  • Coverage of 220+ diseases, vaccines and tumor biomarkers across up to 171 countries
  • Transparent and validated bottom-up methods with proprietary models for exposure-based forecasting
  • Global coverage using validated models of epidemiological transition and geographical extrapolation
  • Estimates based on combinations of publicly available studies, disease registries and in-house real-world data

The complete market picture

Our epidemiology forecasts at the total, diagnosed and drug-treated levels.

The foundation for sizing market potential, profiling patient segments and informing confident forecast-based business decisions.

Total Population

The broadest actual – not extrapolated – geographic coverage and most granular population segments for oncology, rare and niche diseases and beyond.

Want to learn more?
Contact us to connect with a DRG specialist on how we can help you understand the disease landscape and size global markets